Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
Open Access
- 1 August 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (8), 1642-1648
- https://doi.org/10.1161/atvbaha.110.207373
Abstract
Objective— Type 2 diabetes is characterized by impaired β-cell secretory function, insulin resistance, reduced high-density lipoprotein (HDL) levels, and increased cardiovascular risk. Given the current interest in therapeutic interventions that raise HDLs levels, this study investigates the effects of HDLs on insulin secretion from β-cells. Methods and Results— Incubation of Min6 cells and primary islets under basal or high-glucose conditions with either apolipoprotein (apo) A-I or apoA-II in the lipid-free form, as a constituent of discoidal reconstituted HDLs (rHDLs), or with HDLs isolated from human plasma increased insulin secretion up to 5-fold in a calcium-dependent manner. The increase was time and concentration dependent. It was also K ATP channel and glucose metabolism dependent under high-glucose, but not low-glucose, conditions. The lipid-free apolipoprotein-mediated increase in insulin secretion was ATP binding cassette (ABC) transporter A1 and scavenger receptor-B1 dependent. The rHDL-mediated increase in insulin secretion was ABCG1 dependent. Exposure of β-cells to lipid-free apolipoproteins also increased insulin mRNA expression and insulin secretion without significantly depleting intracellular insulin or cholesterol levels. Conclusion— These results establish that lipid-free and lipid-associated apoA-I and apoA-II increase β-cell insulin secretion and indicate that interventions that raise HDLs levels may be beneficial in type 2 diabetes.Keywords
This publication has 19 references indexed in Scilit:
- Cholesterol accumulation and diabetes in pancreatic β-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicityJournal of Lipid Research, 2008
- Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDLJournal of Lipid Research, 2008
- Direct Effect of Cholesterol on Insulin SecretionDiabetes, 2007
- ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular DiseasePhysiological Reviews, 2005
- ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted ApolipoproteinsPublished by Elsevier BV ,2005
- Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 TransporterPublished by Elsevier BV ,2004
- Apolipoprotein A-I Activates Protein Kinase Cα Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein AssemblyPublished by Elsevier BV ,2003
- Insulin-secreting β-Cell Dysfunction Induced by Human LipoproteinsPublished by Elsevier BV ,2003
- Stimulus-secretion coupling in pancreatic β cellsJournal of Cellular Biochemistry, 1994
- Calcium-independent potentiation of insulin release by cyclic AMP in single β-cellsNature, 1993